Home > Insider Trading > Biolinerx Ltd. > Profile

Biolinerx Ltd. (BLRX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

Hedge Fund Popularity

Display

13F filing is ongoing

Display Share Price

Display Standard Version

Hedge Fund Holdings

Filing Period:

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Citadel Investment GroupCALL Ken Griffin	24,100	$26,992	-34%	0%
2.	Citadel Investment GroupPUT Ken Griffin	12,200	$13,664	+178%	0%
3.	Citadel Investment Group Ken Griffin	0	$0	-100%	0%

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Morgan Stanley	238,261	$374,070	0%
2.	Susquehanna International Group, Llp	129,994	$204,091	0%
3.	Susquehanna International Group, LlpPUT	124,600	$195,622	0%
4.	Atria Wealth Solutions, Inc.	110,366	$173,275	0%
5.	Lpl Financial Llc	100,323	$157,507	0%

News See All

BioLineRx Ltd. (NASDAQ:BLRX) Q1 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2024 Financial Results Conference Call. All participants are presently in a listen-only mode.

Keep Reading →

May 29th, 2024 - News Transcripts

BioLineRx Ltd. (NASDAQ:BLRX) Q4 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Fourth Quarter and Full Year 2023 Financial Results Conference Call.

Keep Reading →

March 27th, 2024 - News Transcripts

BioLineRx Ltd. (NASDAQ:BLRX) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Third Quarter 2023 Financial Results Conference Call. All participants are presently in a listen-only mode.

Keep Reading →

November 21st, 2023 - News Transcripts

BioLineRx Ltd. (NASDAQ:BLRX) Q2 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Second Quarter 2023 Financial Results Conference Call. All participants are presently in listen-only mode.

Keep Reading →

August 31st, 2023 - News Transcripts

BioLineRx Ltd. (NASDAQ:BLRX) Q1 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2023 Financial Results Conference Call.

Keep Reading →

May 25th, 2023 - News Transcripts

BioLineRx Ltd. (NASDAQ:BLRX) Q4 2022 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx 2022 Financial Results Conference Call.

Keep Reading →

March 24th, 2023 - News Transcripts

BioLineRx Ltd. (NASDAQ:BLRX) Q3 2022 Earnings Call Transcript

John Lacey: Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements.

Keep Reading →

December 28th, 2022 - News Transcripts

11 Best Stocks for Long Term Growth

As the economy recovers post COVID-19, many investors see the surge in consumer spending and the expansion of the digital economy as megatrends that are bullish for stocks.

Keep Reading →

October 6th, 2021 - Hedge Funds News

Is Bioline RX Ltd (BLRX) A Good Stock To Buy?

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.

Keep Reading →

June 30th, 2021 - Hedge Funds News

Here is What Hedge Funds Think About Bioline RX Ltd (BLRX)

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).

Keep Reading →

December 2nd, 2020 - Hedge Funds News

Click here to See All News